Search Within

Craig Moskowitz

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (13)
  2. Journal Article (6)
Groups
  1. CTCR Scholars (19)
  2. Center for Hematologic Malignancies (19)
  3. Department of Medicine (19)
  4. Hematologic Malignancies, Division of (19)
  5. MSK Grad Students (19)
  6. Master of Science in Clinical and Translational Cancer Research (19)

More Groups

People
  1. Matthew Matasar (15)
  2. Craig Sauter (12)
  3. Parastoo Dahi (12)
  4. Sergio Giralt (11)
  5. Andrew Zelenetz (10)
  6. Paul Hamlin (9)

More People

Years
  1. 2023 (1)
  2. 2021 (1)
  3. 2020 (5)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (8)
  2. Blood (6)
  3. Journal of Clinical Oncology (2)
  4. Blood Cancer Journal (1)
  5. Cancers (1)
  6. European Journal of Cancer (1)
Publishers
  1. Elsevier Inc. (9)
  2. American Society of Hematology (6)
  3. American Society of Clinical Oncology (2)
  4. MDPI (1)
  5. Nature Publishing Group (1)

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma
    Meeting Abstract

    Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Early data from a phase II trial investigating the combination of pembrolizumab (PEM) and entinostat (ENT) in relapsed and refractory (R/R) Hodgkin lymphoma (HL)
    Meeting Abstract

    Sermer, D. J.; Vardhana, S. A.; Ames, A.; Biggar, E.; Moskowitz, A. J.; Batlevi, C. L.; Caron, P.; Hamilton, A. M.; Moskowitz, C. H.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma in the modern era: Survival, treatment outcomes, and identification of high-risk subgroups
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Soumerai, J. D.; Caron, P. C.; Falchi, L.; Hamilton, A.; more...
    Blood Cancer Journal (2020)

    Fulltext@MSK | Save
  • Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma
    Journal Article

    Batlevi, C. L.; Sha, F.; Alperovich, A.; Ni, A.; Smith, K.; Ying, Z.; Gerecitano, J. F.; Hamlin, P. A.; Horwitz, S. M.; Joffe, E.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Efficacy of revaccination after autologous hematopoietic stem cell transplantation in lymphoma patients with or without rituximab exposure
    Meeting Abstract

    Preston, E. V.; Palazzo, M.; Seier, K.; Maloy, M. A.; Devlin, S. M.; Giralt, S. A.; Scordo, M.; Dahi, P. B.; Matasar, M. J.; Moskowitz, C. H.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicities associated with high dose chemotherapy and autologous stem cell transplantation in older patients with non-Hodgkin lymphoma
    Meeting Abstract

    Dahi, P. B.; Rondon Clavo, C.; Maloy, M.; Seier, K.; Devlin, S. M.; Robinson, K.; Scordo, M.; Shah, G. L.; Tamari, R.; Matasar, M. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicities after Evomela® (propylene glycol free melphalan) with hematopoietic stem cell transplant (HCT) for multiple myeloma (MM), AL amyloidosis (AL), lymphoma, acute myeloid leukemia (AML), and myelodysplastic syndrome (MDS)
    Meeting Abstract

    Shah, G. L.; Landau, H.; Sarubbi, C.; Schofield, R.; Lin, A.; Bhatt, V.; Harnicar, S.; Devlin, S. M.; Castro-Malaspina, H.; Chung, D. J.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save